This grant has supported the identification of bone marrow-derived cell types with characteristics of macrophage and dendritic cell progenitors as sites of CMV latency, provided evidence that the latent viral genome configuration circular similar to a plasmid, constructed a number of viral mutants to address the role of viral functions in latency and established the relationship between viral genome and latent transcript positive cells. We propose to continue investigations that seek to unravel the genetic and molecular basis of viral control of latency and reactivation, using granulocyte-macrophage progenitor cultures as the experimental system. The physiological role of viral genes in latency and reactivation will be investigated with a panel of mutant viruses and assays to test latency-associated gene functions. First, we will complete a function evaluation of previously characterized latent and immediate early (a) gene products in the establishment, maintenance and reactivation of latency in granulocyte-macrophage progenitor cultures. Second, we will investigate the cellular localization and function of ORFs that have been identified on ie1/ie2 region latent transcripts. Here we will investigate ORF94 which localizes to the nucleus and nucleolus and determine its role in nuclear shuffling, RNA binding and RNA splicing. Third, we will identify additional viral genes that are expressed during latency and reactivation using a set of PCR primers that have been made to all viral ORFs. This will complete the identification of latent genes on the viral genome. Here we will focus on UL112-113 region transcripts that have been detected in CMV strain Toledo infected GM-Ps. We will also undertake systematic RT-PCR amplification of all viral ORFs using a set of CMV ORF-specific PCR primers we have assembled. This work will continue to build an understanding of viral functions expressed during and involved in latency of this important pathogen and will continue to provide insights that can be evaluated in naturally infected individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI033852-07
Application #
6169844
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Beisel, Christopher E
Project Start
1994-08-01
Project End
2004-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
7
Fiscal Year
2000
Total Cost
$234,903
Indirect Cost
Name
Stanford University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Vana, Marcy L; Formankova, Danuse; Cha, Steven et al. (2008) Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation. Clin Infect Dis 47:535-9
Noda, Satoshi; Aguirre, Shirley A; Bitmansour, Andrew et al. (2006) Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood 107:30-8
Slobedman, Barry; Stern, J Lewis; Cunningham, Anthony L et al. (2004) Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J Virol 78:4054-62
Abate, Davide A; Watanabe, Shinya; Mocarski, Edward S (2004) Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol 78:10995-1006
Hertel, Laura; Mocarski, Edward S (2004) Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function. J Virol 78:11988-2011
Hertel, Laura; Lacaille, Vashti G; Strobl, Herbert et al. (2003) Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol 77:7563-74
Slobedman, Barry; Mocarski, Edward S; Arvin, Ann M et al. (2002) Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood 100:2867-73
Saederup, N; Aguirre, S A; Sparer, T E et al. (2001) Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol 75:9966-76
White, K L; Slobedman, B; Mocarski, E S (2000) Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J Virol 74:9333-7
Slobedman, B; Mocarski, E S (1999) Quantitative analysis of latent human cytomegalovirus. J Virol 73:4806-12

Showing the most recent 10 out of 17 publications